Atlas
Market PulseMovers & ShakersSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › AMRUTANJAN

AMRUTANJAN

Amrutanjan Health Care Limited
Micro-capPharma ↗

What the six lenses say about AMRUTANJAN — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹500.3
2026-09-08
VWAP · 1Y anchor
₹566
-11.6% from VWAP
P/E · TTM
—
no TTM EPS
52-week range
4%
position low→high
RSI(14)
42
momentum

Own sector index

Pharma ↗
Overweight

1M

+0.4%

3M

+10.5%

1Y

+22.0%

Breadth >EMA21

56%

How AMRUTANJAN’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
2.0
avg conviction decile
Leadership
—
top-decile composite in cohort
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Micro-cap cohortDRaw
TechnicalD23›

The actual numbers

Price vs VWAP (1y)-11.6%
EMA trend stackDown · 21<50<200
Price vs 200-EMA-12.8%
Price vs 50-EMA-4.1%
RSI(14)42
RS vs Nifty 500 · 3M-14.6%
RS vs sector · 3M-20.6%
52-week range4%
Volume vs 30d avg0.32×
Volume vs 60d avg0.44×
ATR(14) · volatility17.8
Bollinger width · vol contraction0.120
FundamentalD855›

The actual numbers

Return on equity (ROE)17.1%
Operating margin15.4%
Net margin11.1%
Revenue growth · YoY+12.4%
EPS growth · YoY+12.5%
Debt / equity0.00×

Full 8-quarter history in the financials table below.

ValuationD748›

The actual numbers

52-week range4%
CatalystD331›

The actual numbers

Earnings & momentum22
Capital actions39
Governance49

Every filing in the corporate-announcements panel below.

FlowD240›

The actual numbers

Promoter holding46.5%
Delivery · 30d avg57.0%
Up/down-day asymmetry-2.0pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Micro-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D2 + D2 ) ÷ 2 = 2.0(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Below threshold
6
Conviction score 6/100 · avg-decile strength 2.0/10
Conviction score6/100›
TechnicalD2›
FundamentalD8›
ValuationD7›
CatalystD3›
FlowD2›

Policy

Government policy · Pharma

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
-0.5pp
-0.5pp
-0.3pp
-13.0pp
-7.9pp
-30.5pp
Nifty 500
Broad-market baseline
-0.6pp
-0.5pp
-1.4pp
-14.6pp
-13.7pp
-35.7pp
Sector
Own-sector index
—
—
-4.2pp
-20.6pp
-26.8pp
-56.5pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

AMRUTANJAN daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
500.30-5.15

Relative strength

RS vs baseline · rebased to 100

AMRUTANJAN ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
63.64-0.38

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

No quarterly financials available.

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 28 Aug '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 12 Aug '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 11 Aug '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 5 Aug '26
    LOWgovernance
    Commencement of commercial production/operations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 5 Aug '26
    MEDIUMcapital
    Credit Rating
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 1 Aug '26
    LOWgovernance
    Action(s) taken or orders passed
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 19 Jun '26
    LOWgovernance
    General Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 15 Jun '26
    MEDIUMgovernance
    Disclosure under SEBI Takeover Regulations
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 27 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 26 May '26
    MEDIUMgovernance
    Change in Director(s)
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 13 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 9 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 8 May '26
    LOWgovernance
    Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds AMRUTANJAN

Mutual funds holding AMRUTANJAN (2)

FundWeightAUM ₹crGrade
ICICI Pru FMCG Gr2.08%1,631
ICICI Prudential Balanced Hyb Reg Gr1.49%0

ETFs holding AMRUTANJAN (0)

No tracked ETF holds AMRUTANJAN ≥0.5%.

Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Pharma